Piper Jaffray Starts Medgenics (MDGN) at Overweight, $7 PT
Tweet Send to a Friend
Piper Jaffray initiates coverage on Medgenics (NYSE: MDGN) with a Overweight rating and a price target of $7.00.Analyst Edward Tenthoff ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
